Health3 weeks ago
Empowering Progress: Joining Forces for Targeted Ovarian Cancer Medications
NOVARC at University of Nottingham collaborates with XPose Therapeutics to develop molecular-level drugs targeting ovarian cancer. Renamed in honor of Naaz Coker, the research center aims...